{"id":594887,"title":"Canada's Prescription Drug List: Additions (2019-10-04) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-04","captureTimestamp":"2026-03-04T13:28:10.536000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-10-04.html","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Date: October 7, 2019 Our file number: 19-119291-196 The purpose of this Notice of Amendment is to notify about the additions of acalabrutinib, galcanezumab, larotrectinib, mannitol, neratinib, niraparib, ravulizumab,…","rawSnapshotUrl":"/api/snapshots/raw/594887","browseUrl":"https://replay.healtharchive.ca/job-6/20260304132810/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-10-04.html#ha_snapshot=594887","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}